Biotech Stock News (ACAD) (RXII) (REGN) (AZN) (ZSPH)

Acadia Pharmaceuticals (NASDAQ:ACAD) On November 3, 2015 Acadia had announced that the FDA had given its Parkinson’s Drug, NUPLAZID, FDA priority review. To understand what this means, we must first understand what the FDA priority review actually means? A company is only given FDA priority review if the drug it has developed treats an unmet … Read more

Biotech Stock News (RXII) (REGN) (SURG) (VRX) (ACAD)

Rxi Pharmaceuticals (NASDAQ:RXII) On August 31, 2015 Rxi announced that the 30-day review period for its IND of RXI-109 for scarring of macular degeneration has passed its review period and the IND is now active. The whole point of the 30-day review period is for the FDA to look at pre-clinical data and conclude whether … Read more

Biotech Stock News (INO) (AZN) (IMUC) (AAVL) (REGN)

Inovio Pharmaceuticals (NASDAQ:INO) On August 10, 2015 shares of Inovio were up about 25% after the company announced a partnership deal with a big pharmaceutical company known as AstraZeneca (NYSE:AZN). Although one key thing to note here is that this deal is being established with MedImmune specifically, but it is the research and development arm for … Read more

Analysts Weigh In on Regeneron Pharmaceuticals Inc (REGN) Following Earnings Report

By Cody Miecnikowski On Tuesday, August 4, before market open, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported its second-quarter 2015 financial results that beat both top and bottom line expectations. The biotech giant, which recently won approval for its cholesterol drug, Praluent, said its profit doubled in its second quarter as sales of Eylea, its eye-disease treatment, surged. Specifically, the company’s revenue jumped 50% year-over-year to $998.6 … Read more

Regeneron Pharmaceuticals (REGN) Tops Q2 Earnings

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Regeneron Pharmaceuticals stock is having a great day in the market today after releasing its results from the second quarter. Today, we’ll take a look at REGN’s Q2 results, how investors reacted to the news, and what we can expect to see moving forward. So, let’s get right to it… … Read more

Biotech Stock News (AAVL) (AERI) (AGN) (KYTH) (RHHBY) (REGN) (PFE) (NVS)

Avalanche Biotech (NASDAQ:AAVL) Shares of Avalanche Biotech fell as much as 40% in after-hours trading on June 15, 2015 after the company announced results from its phase 2 wet-age related macular degeneration — wet-AMD — trial. The drop is huge but many investors should be assured that the drop was justified because the results were … Read more

Hot BioTech Stocks Today

Most BioTech stocks seem to be in the red today. We suspect that the downtrends in the market today have quite a bit to do with the Federal Reserve’s 2 day meeting that ends tomorrow. Nonetheless, here’s what we saw from BioTech stocks today… Fastest Growing BioTech Stocks Today Orexigen Therapeutics, Inc. (NASDAQ: OREX) – … Read more

Today’s Top Movers In The Market

As always, today was an exciting day in the market. Here’s a list of the top moving stocks by industry today… Tech’s Biggest Moving Stocks Tech’s Fastest Growing Stocks Today Apple (AAPL) – Apple stocks closed the day off at $124.25 per share after a gain of $1.36 or 1.10%. MicroVision (MVIS) – MicroVision stocks … Read more

BioTech Stocks Today | CYTX | INO | GENE | REGN | MNKD

Cytori (CYTX) Stocks Continue To Climb Following Poor Earnings I’ve always found it interesting when a company produces a poor earnings report, but their stocks react in a positive way. For instance, look at Amazon for the life of its performance in the stock market! Nonetheless, Cytori (CYTX) seems to be capable of doing just … Read more

Hot Stocks To Watch This Week

Will Apple (AAPL) Stocks Make A Recovery This Week? While Apple (AAPL) is the largest company in the world, their business isn’t immune to mistakes. After a botched Spring Forward event last Monday, Apple (AAPL) stocks started to decline. Throughout the week, there were ups and downs as always; but for the most part, what … Read more